Found: 122
Select item for more details and to access through your institution.
SARS-CoV-2 Viral Persistence Based on Cycle Threshold Value and Liver Injury in Patients With COVID-19.
- Published in:
- Open Forum Infectious Diseases, 2021, v. 8, n. 6, p. 1, doi. 10.1093/ofid/ofab205
- By:
- Publication type:
- Article
Respiratory admissions before and during the COVID‐19 pandemic with mediation analysis of air pollutants, mask‐wearing and influenza rates.
- Published in:
- Respirology, 2023, v. 28, n. 1, p. 47, doi. 10.1111/resp.14345
- By:
- Publication type:
- Article
CAGE‐B and SAGE‐B models better predict the hepatitis B virus‐related hepatocellular carcinoma after 5‐year entecavir treatment than PAGE‐B.
- Published in:
- Journal of Digestive Diseases, 2023, v. 24, n. 2, p. 113, doi. 10.1111/1751-2980.13172
- By:
- Publication type:
- Article
Measuring spleen stiffness to predict varices in chronic hepatitis B cirrhotic patients with or without receiving non-selective beta-blockers.
- Published in:
- Journal of Digestive Diseases, 2016, v. 17, n. 8, p. 538, doi. 10.1111/1751-2980.12359
- By:
- Publication type:
- Article
High incidence of hepatocellular carcinoma and cirrhotic complications in patients with psychiatric illness: a territory-wide cohort study.
- Published in:
- 2020
- By:
- Publication type:
- journal article
The effect of caffeine and alcohol consumption on liver fibrosis - a study of 1045 Asian hepatitis B patients using transient elastography.
- Published in:
- Liver International, 2011, v. 31, n. 7, p. 1047, doi. 10.1111/j.1478-3231.2011.02555.x
- By:
- Publication type:
- Article
Surveillance programme for hepatocellular carcinoma improves the survival of patients with chronic viral hepatitis.
- Published in:
- Liver International, 2008, v. 28, n. 1, p. 79, doi. 10.1111/j.1478-3231.2007.01576.x
- By:
- Publication type:
- Article
Tenofovir alafenamide is associated with improved alanine aminotransferase and renal safety compared to tenofovir disoproxil fumarate.
- Published in:
- Journal of Medical Virology, 2022, v. 94, n. 9, p. 4440, doi. 10.1002/jmv.27863
- By:
- Publication type:
- Article
CAMP‐B score predicts the risk of hepatocellular carcinoma in patients with chronic hepatitis B after HBsAg seroclearance.
- Published in:
- Alimentary Pharmacology & Therapeutics, 2024, v. 59, n. 10, p. 1223, doi. 10.1111/apt.17933
- By:
- Publication type:
- Article
Machine learning improves the prediction of significant fibrosis in Asian patients with metabolic dysfunction‐associated steatotic liver disease – The Gut and Obesity in Asia (GO‐ASIA) Study.
- Published in:
- Alimentary Pharmacology & Therapeutics, 2024, v. 59, n. 6, p. 774, doi. 10.1111/apt.17891
- By:
- Publication type:
- Article
Atherosclerotic cardiovascular disease risk profile of patients with chronic hepatitis B treated with tenofovir alafenamide or tenofovir disoproxil fumarate for 96 weeks.
- Published in:
- Alimentary Pharmacology & Therapeutics, 2024, v. 59, n. 2, p. 217, doi. 10.1111/apt.17764
- By:
- Publication type:
- Article
MAFLD fibrosis score: Using routine measures to identify advanced fibrosis in metabolic‐associated fatty liver disease.
- Published in:
- Alimentary Pharmacology & Therapeutics, 2023, v. 58, n. 11/12, p. 1194, doi. 10.1111/apt.17722
- By:
- Publication type:
- Article
Editorial: Can liver fat quantification stratify cardiovascular risk in type 2 diabetes?
- Published in:
- Alimentary Pharmacology & Therapeutics, 2023, v. 58, n. 10, p. 1107, doi. 10.1111/apt.17677
- By:
- Publication type:
- Article
Letter: Rethinking the lower incidence of HCC in HIV‐infected patients—A closer look at confounding factors. Authors' reply.
- Published in:
- Alimentary Pharmacology & Therapeutics, 2023, v. 58, n. 9, p. 958, doi. 10.1111/apt.17713
- By:
- Publication type:
- Article
Risk and predictors of hepatic decompensation in grey zone patients by the Baveno VII criteria: A competing risk analysis.
- Published in:
- Alimentary Pharmacology & Therapeutics, 2023, v. 58, n. 9, p. 920, doi. 10.1111/apt.17699
- By:
- Publication type:
- Article
Incidence of hepatocellular carcinoma and mortality in chronic viral hepatitis in an Asian population with and without HIV infection.
- Published in:
- Alimentary Pharmacology & Therapeutics, 2023, v. 58, n. 8, p. 814, doi. 10.1111/apt.17654
- By:
- Publication type:
- Article
improvement of cardiovascular risk factor control in patients with type 2 diabetes and nonalcoholic fatty liver disease--time for action! Authors' reply.
- Published in:
- Alimentary Pharmacology & Therapeutics, 2023, v. 57, n. 10, p. 1172, doi. 10.1111/apt.17474
- By:
- Publication type:
- Article
Trends in risk factor control and treatment among patients with non-alcoholic fatty liver disease and type 2 diabetes between 2000 and 2020: A territory-wide study.
- Published in:
- Alimentary Pharmacology & Therapeutics, 2023, v. 57, n. 10, p. 1103, doi. 10.1111/apt.17428
- By:
- Publication type:
- Article
Letter: vaccination for global control of hepatitis B—from prevention to elimination. Authorsʼ reply.
- Published in:
- Alimentary Pharmacology & Therapeutics, 2022, v. 56, n. 11/12, p. 1629, doi. 10.1111/apt.17271
- By:
- Publication type:
- Article
Universal HBV vaccination dramatically reduces the prevalence of HBV infection and incidence of hepatocellular carcinoma.
- Published in:
- Alimentary Pharmacology & Therapeutics, 2022, v. 56, n. 5, p. 869, doi. 10.1111/apt.17120
- By:
- Publication type:
- Article
Letter: systematic review with meta‐analysis on the impact of functional cure on clinical outcomes in patients with chronic hepatitis B.
- Published in:
- Alimentary Pharmacology & Therapeutics, 2022, v. 55, n. 5, p. 616, doi. 10.1111/apt.16758
- By:
- Publication type:
- Article
Screening for compensated advanced chronic liver disease using refined Baveno VI elastography cutoffs in Asian patients with nonalcoholic fatty liver disease.
- Published in:
- Alimentary Pharmacology & Therapeutics, 2021, v. 54, n. 4, p. 470, doi. 10.1111/apt.16487
- By:
- Publication type:
- Article
Similarly low risk of hepatocellular carcinoma after either spontaneous or nucleos(t)ide analogue‐induced hepatitis B surface antigen loss.
- Published in:
- Alimentary Pharmacology & Therapeutics, 2021, v. 53, n. 2, p. 321, doi. 10.1111/apt.16174
- By:
- Publication type:
- Article
Liver-FibroSTARD checklist and glossary: tools for standardized design and reporting of diagnostic accuracy studies of liver fibrosis tests.
- Published in:
- 2015
- By:
- Publication type:
- Editorial
Macromolecular proton fraction mapping based on spin‐lock magnetic resonance imaging.
- Published in:
- Magnetic Resonance in Medicine, 2020, v. 84, n. 6, p. 3157, doi. 10.1002/mrm.28362
- By:
- Publication type:
- Article
Modelling the economic and clinical burden of non‐alcoholic steatohepatitis in East Asia: Data from Hong Kong.
- Published in:
- Hepatology Research, 2020, v. 50, n. 9, p. 1024, doi. 10.1111/hepr.13535
- By:
- Publication type:
- Article
Diet-Quality Scores and Prevalence of Nonalcoholic Fatty Liver Disease: A Population Study Using Proton-Magnetic Resonance Spectroscopy.
- Published in:
- PLoS ONE, 2015, v. 10, n. 9, p. 1, doi. 10.1371/journal.pone.0139310
- By:
- Publication type:
- Article
Higher Estimated Net Endogenous Acid Production May Be Associated with Increased Prevalence of Nonalcoholic Fatty Liver Disease in Chinese Adults in Hong Kong.
- Published in:
- PLoS ONE, 2015, v. 10, n. 4, p. 1, doi. 10.1371/journal.pone.0122406
- By:
- Publication type:
- Article
Molecular Characterization of the Fecal Microbiota in Patients with Nonalcoholic Steatohepatitis – A Longitudinal Study.
- Published in:
- PLoS ONE, 2013, v. 8, n. 4, p. 1, doi. 10.1371/journal.pone.0062885
- By:
- Publication type:
- Article
Bacterial Microbiota Profiling in Gastritis without Helicobacter pylori Infection or Non-Steroidal Anti- Inflammatory Drug Use.
- Published in:
- PLoS ONE, 2009, v. 4, n. 11, p. e7985, doi. 10.1371/journal.pone.0007985
- By:
- Publication type:
- Article
Differential Impacts of Multimorbidity on COVID-19 Severity across the Socioeconomic Ladder in Hong Kong: A Syndemic Perspective.
- Published in:
- International Journal of Environmental Research & Public Health, 2021, v. 18, n. 15, p. 8168, doi. 10.3390/ijerph18158168
- By:
- Publication type:
- Article
Medication Burden Among Pediatric Cancer Survivors: Analysis of a Population-Wide Electronic Database in Hong Kong.
- Published in:
- JNCI Cancer Spectrum, 2022, v. 6, n. 5, p. 1, doi. 10.1093/jncics/pkac059
- By:
- Publication type:
- Article
Reply to Allaire, M.; Thabut, D. Comment on "Wu et al. Baveno VII Criteria Is an Accurate Risk Stratification Tool to Predict High-Risk Varices Requiring Intervention and Hepatic Events in Patients with Advanced Hepatocellular Carcinoma. Cancers 2023, 15 , 2480"
- Published in:
- Cancers, 2024, v. 16, n. 4, p. 725, doi. 10.3390/cancers16040725
- By:
- Publication type:
- Article
Baveno VII Criteria Is an Accurate Risk Stratification Tool to Predict High-Risk Varices Requiring Intervention and Hepatic Events in Patients with Advanced Hepatocellular Carcinoma.
- Published in:
- Cancers, 2023, v. 15, n. 9, p. 2480, doi. 10.3390/cancers15092480
- By:
- Publication type:
- Article
AI‐powered prediction of HCC recurrence after surgical resection: Personalised intervention opportunities using patient‐specific risk factors.
- Published in:
- Liver International, 2024, v. 44, n. 10, p. 2724, doi. 10.1111/liv.16050
- By:
- Publication type:
- Article
Serum PRO‐C3 is useful for risk prediction and fibrosis assessment in MAFLD with chronic kidney disease in an Asian cohort.
- Published in:
- Liver International, 2024, v. 44, n. 5, p. 1129, doi. 10.1111/liv.15878
- By:
- Publication type:
- Article
Machine‐learning model comprising five clinical indices and liver stiffness measurement can accurately identify MASLD‐related liver fibrosis.
- Published in:
- Liver International, 2024, v. 44, n. 3, p. 749, doi. 10.1111/liv.15818
- By:
- Publication type:
- Article
Liver stiffness measurement predicts long‐term survival and complications in non‐alcoholic fatty liver disease.
- Published in:
- Liver International, 2020, v. 40, n. 3, p. 581, doi. 10.1111/liv.14301
- By:
- Publication type:
- Article
Impact of dose and duration of corticosteroid on the risk of hepatitis flare in patients with chronic hepatitis B.
- Published in:
- Liver International, 2019, v. 39, n. 2, p. 271, doi. 10.1111/liv.13953
- By:
- Publication type:
- Article
Poor adherence to hepatocellular carcinoma surveillance: A systematic review and meta‐analysis of a complex issue.
- Published in:
- Liver International, 2018, v. 38, n. 3, p. 503, doi. 10.1111/liv.13555
- By:
- Publication type:
- Article
Epidemiology, Symptomatology, and Risk Factors for Long COVID Symptoms: Population-Based, Multicenter Study.
- Published in:
- JMIR Public Health & Surveillance, 2023, v. 9, p. 484, doi. 10.2196/42315
- By:
- Publication type:
- Article
Clinical Outcomes Following Treatment for COVID-19 With Nirmatrelvir/Ritonavir and Molnupiravir Among Patients Living in Nursing Homes.
- Published in:
- JAMA Network Open, 2023, v. 6, n. 4, p. e2310887, doi. 10.1001/jamanetworkopen.2023.10887
- By:
- Publication type:
- Article
Incidence of Viral Rebound After Treatment With Nirmatrelvir-Ritonavir and Molnupiravir.
- Published in:
- JAMA Network Open, 2022, v. 5, n. 12, p. e2245086, doi. 10.1001/jamanetworkopen.2022.45086
- By:
- Publication type:
- Article
Importance-aware personalized learning for early risk prediction using static and dynamic health data.
- Published in:
- 2021
- By:
- Publication type:
- journal article
Pattern and impact of hepatic adverse events encountered during immune checkpoint inhibitors – A territory‐wide cohort study.
- Published in:
- Cancer Medicine, 2020, v. 9, n. 19, p. 7052, doi. 10.1002/cam4.3378
- By:
- Publication type:
- Article
Dipeptidyl peptidase-4 inhibitors are associated with improved survival of patients with diabetes mellitus and hepatocellular carcinoma receiving immunotherapy: Letter to the editor on “Statin and aspirin for chemoprevention of hepatocellular carcinoma: Time to use or wait further?”.
- Published in:
- Clinical & Molecular Hepatology, 2024, v. 30, n. 4, p. 970, doi. 10.3350/cmh.2024.0280
- By:
- Publication type:
- Article
Unlocking the future: Machine learning sheds light on prognostication for early-stage hepatocellular carcinoma: Editorial on “Conventional and machine learning-based risk scores for patients with early-stage hepatocellular carcinoma”.
- Published in:
- Clinical & Molecular Hepatology, 2024, v. 30, n. 4, p. 698, doi. 10.3350/cmh.2024.0327
- By:
- Publication type:
- Article
Non-invasive biomarkers for liver inflammation in non-alcoholic fatty liver disease: present and future.
- Published in:
- Clinical & Molecular Hepatology, 2023, v. 29, p. S171, doi. 10.3350/cmh.2022.0426
- By:
- Publication type:
- Article
Moving toward hepatitis B virus functional cure - the impact of on-treatment kinetics of serum viral markers.
- Published in:
- Clinical & Molecular Hepatology, 2023, v. 29, n. 1, p. 113, doi. 10.3350/cmh.2022.0333
- By:
- Publication type:
- Article
U-shaped relationship between urea level and hepatic decompensation in chronic liver diseases.
- Published in:
- Clinical & Molecular Hepatology, 2022, v. 28, n. 1, p. 77, doi. 10.3350/cmh.2021.0188
- By:
- Publication type:
- Article